Elevance Health, Inc. (ELV)
(Delayed Data from NYSE)
$503.89 USD
+3.77 (0.75%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $504.14 +0.25 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth A Momentum B VGM
Price, Consensus and EPS Surprise
ELV 503.89 +3.77(0.75%)
Will ELV be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ELV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ELV
Boston Scientific (BSX) Banks on Global Expansion, Innovation
Glaukos (GKOS) Gains 51.9% YTD: What's Driving the Stock?
ELV: What are Zacks experts saying now?
Zacks Private Portfolio Services
GE HealthCare (GEHC) New Deal to Aid Its Ultrasound Portfolio
Hyperfine's (HYPR) Swoop System Gets New FDA-Cleared Software
Elevance Health's (ELV) Q2 Earnings Beat on Lower Benefit Expense
Other News for ELV
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Elevance Health (ELV), CVS Health (CVS) and Abbott Laboratories (ABT)
Insider Sale: Director Dixon Robert L JR Sells Shares of Elevance Health Inc (ELV)
Kamala Harris' potential impact on health care stocks
A Closer Look at Elevance Health's Options Market Dynamics
Elevance extends losses as BofA cuts on Medicaid headwinds